BD to Present at the 40th Annual J.P. Morgan Healthcare Conference

Rhea-AI Summary

BD (Becton, Dickinson and Company) (NYSE: BDX), a prominent medical technology leader, will present at the 40th Annual J.P. Morgan Healthcare Conference on January 11, 2022, at 2:15 p.m. Eastern Time. The presentation will be accessible via live webcast on BD's investor relations website, with a replay available afterward. BD focuses on advancing health through technology, diagnostics, and care delivery, supporting healthcare providers and enhancing patient outcomes globally.

FRANKLIN LAKES, N.J., Dec. 22, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that it will virtually present at the 40th Annual J.P. Morgan Healthcare Conference via webcast. BD's management is scheduled to present on Tuesday, January 11, 2022 at 2:15 p.m. Eastern Time.

The live webcast of BD's presentation can be accessed from the BD investor relations website, investors.bd.com. A replay of the event will be available on the same webpage following its conclusion.

About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.

Contacts:
Troy Kirkpatrick				Francesca DeMartino
VP, Public Relations				SVP, Head of Investor Relations
858.617.2361				201.847.5743
troy.kirkpatrick@bd.com				francesca.demartino@bd.com

 

View original content to download multimedia:https://www.prnewswire.com/news-releases/bd-to-present-at-the-40th-annual-jp-morgan-healthcare-conference-301449973.html

SOURCE BD (Becton, Dickinson and Company)

FAQ

When will BD present at the J.P. Morgan Healthcare Conference?

BD will present on January 11, 2022, at 2:15 p.m. Eastern Time.

How can I access BD's presentation at the healthcare conference?

The presentation can be accessed via live webcast on BD's investor relations website.

Is there a replay for BD's conference presentation available?

Yes, a replay of the presentation will be available on the investor relations website after the event.

What is the stock symbol for BD?

The stock symbol for BD is BDX.

What is BD's focus in the healthcare industry?

BD focuses on improving medical discovery, diagnostics, and the delivery of care.